help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Handley, D. A.
Right arrow Articles by Saunders, R. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Handley, D. A.
Right arrow Articles by Saunders, R. N.

American Journal of Pathology, Vol 124, 88-93, Copyright © 1986 by American Society for Investigative Pathology

REGULAR ARTICLES

Suppression of rat carotid lesion development by the calcium channel blocker PN 200-110

DA Handley, RG Van Valen, MK Melden and RN Saunders

Balloon catheter damage of the rat carotid artery endothelium results in an extensive and reproducible neointimal lesion composed of smooth muscle cells and connective matrix. The authors have examined two calcium channel blockers, PN 200-110 and PY 108-068, for their ability to inhibit neointimal lesion development in the rat carotid model. When given subcutaneously (1.0 mg/kg day) both compounds produced rapidly acting and long-lasting hypotension, reducing blood pressure 25-29%. At this dose given daily, PN 200-110 reduced lesion cross-sectional area by 44%, compared with only 25% seen by PY 108-068, which suggests that the antiatherosclerotic effect may not be related to lowering of blood pressure. Furthermore, PN 200-110 did not reduce the extent of platelet deposition (compared with controls) occurring at the denuded vessel surface 1 hour or 24 hours after balloon catheterization, which indicates that the inhibition of lesion development may not reflect an antiplatelet mechanism. The observed inhibition by PN 200-110 may relate to mitogen responses of the smooth muscle cell in the vessel wall (migration and proliferation) involved in lesion progression after endothelial damage.


This article has been cited by other articles:


Home page
 Cardiovasc ResHome page
M. C. Verhaar, M. L.H. Honing, T. van Dam, M. Zwart, H. A. Koomans, J. J.P. Kastelein, and T. J. Rabelink
Nifedipine improves endothelial function in hypercholesterolemia, independently of an effect on blood pressure or plasma lipids
Cardiovasc Res, June 1, 1999; 42(3): 752 - 760.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. S. Schroeder, S.-Z. Gao, E. L. Alderman, S. A. Hunt, I. Johnstone, D. B. Boothroyd, V. Wiederhold, and E. B. Stinson
A Preliminary Study of Diltiazem in the Prevention of Coronary Artery Disease in Heart-Transplant Recipients
N. Engl. J. Med., January 21, 1993; 328(3): 164 - 170.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by the American Society for Investigative Pathology.